Fresenius Kabi

Fresenius Medical Care

Fresenius Digital Technology

Fresenius Investor Relations

Helios Health GmbH

“Advancing patient care” – we strive to improve continuously and to shape the future of healthcare as an industry-leading, therapy-focused healthcare company. 

We offer system-critical products and services for leading therapies for the care of critically and chronically ill patients. In fiscal year 2022, Fresenius generated €21.5 billion in annual revenue with around 190,000 employees (excluding Fresenius Medical Care).

The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios and the Investment Companies Fresenius Medical Care and Fresenius Vamed. Each business segment is market leader in a major growth area of healthcare.

Why work for Fresenius?
You spend a significant part of your life in the workplace. Isn't that why you aim high when choosing your job? And this makes Fresenius the right place for you. Our health-care company offers you a special kind of career - a career with a purpose. This means that every day, your work supports our goal of providing better medicine for more people.

Who do we look for?
Engineers, physicians, computer scientists, nursing professionals, pharmacists, economists and scientists, to name but a few - Fresenius offers attractive career opportunities to people of all stripes, in fields such as purchasing, sales, marketing, R&D and production. And at Fresenius, it is not unusual for people to successfully apply their talents in different professional fields: scientists forge careers as managers; nurses enjoy success in sales.

Please find more information on your options to embark on a career at Fresenius on our international career portal: https://careers.fresenius.com/

Other Social Media Channels: 
Instagram: https://www.instagram.com/freseniuscareers/
Facebook: https://www.facebook.com/freseniuskarriere/
Twitter: https://twitter.com/Fresenius_Jobs

Imprint:
https://www.fresenius.com/Imprint

Data protection: 
https://www.fresenius.com/data-protection

Elliott Management

Fresenius Group

With the beginning of every new year come resolutions in terms of health, well-being, and often fitness. At the same time, January 1 marks the start of #Veganuary, a month promoting plant-based diets and a vegan lifestyle. 
 
🌱 Contrary to popular belief, a well-balanced plant-based diet rich in vegetables, fruits, nuts, and other legumes can fuel the body with important nutrients such as fiber, protein, and antioxidants.
 
🔬 Studies also show that a healthy and balanced plant-based lifestyle can reduce the risk of heart disease, certain types of cancer, and type 2 diabetes, while helping to control weight and improving health in general. 
 
🌍 Beyond the personal benefits, choosing a plant-based diet reduces our environmental impact by cutting emissions, saving energy, and conserving natural resources, such as water.
 
At Helios Kliniken GmbH nutritious vegetarian and vegan meals are part of the standard selection for patients. In a recent interview with Fresenius editor Brigitte Baas, the two-Michelin-star chef Hendrik Otto and ecotrophologist Verena Kaiser from Helios discussed their approach to implementing vegan, low-meat, and vegetarian catering options in clinics, tailored to patients’ dietary needs. 
 
Read the full interview here: https://lnkd.in/g64ikDvW
 
#health #resolutions

In an interview with CNBC during the first day of the World Economic Forum's Annual Meeting in Davos, our CEO Michael Sen discusses among others Fresenius' pursuit to combat health inequalities and to close the health gap. #WEF24
 
Watch the full interview here: https://lnkd.in/esDHGzMD

Fresenius has signed the World Economic Forum's Zero Health Gaps Pledge ahead of the upcoming Annual Meeting 2024 in Davos.
 
Improving people's health and advancing patient care is Fresenius' corporate purpose and an important part of the company's ESG strategy. By signing the pledge, Fresenius commits to acting responsibly and working together for equal opportunities in healthcare.
 
The global, cross-sector pledge is a direct response to the persistent and increasing inequalities in healthcare around the world. The action plan including ten commitments promoting equal opportunities in healthcare is part of the Global Health Equity Network (GHEN), which brings together key players from the public and private sectors to advance a shared vision of health equity in line with the UN Sustainable Development Goals (SDGs). 
 
To date, more than 80 companies have signed the world's first voluntary commitment of this kind.

https://lnkd.in/eYdYvz-z

With the upcoming World Economic Forum's Annual Meeting 2024 in Davos, our CEO Michael Sen outlined five crucial steps through which the healthcare industry can jump on the AI fast-track. #WEF24
 
Read the full article here: https://lnkd.in/erAbyfUR

Happy New Year to you and your loved ones!✨ Our best wishes for a year full of health, happiness, and new opportunities.

#HappyNewYear #2024 #Fresenius

The holiday spirit has officially taken over our offices! 🌏✨ From festive decorations to cheerful vibes, we're spreading the joy of the season. Wishing everyone a wonderful holiday season filled with laughter and shared moments of happiness! 💙🎄  #HappyHolidays #TeamFresenius

As part of our annual Give Joy campaign, #Fresenius employees at headquarters in #BadHomburg donated #presents to local charities for about 300 children in need and made generous monetary donations to a local hospice that cares for children and young people with cancer as well as their families. 🎁 What a great way to start off the holiday season! We want to thank everyone who supported this initiative! 💙 #givejoy #supportyourlocals

Celebrate the radiant tradition of #Hanukkah - eight days, nine candles, one shared happiness. May the light of this festive season bring #warmth and #joy into your life! 🕎✨

#HappyHanukkah #HanukkahCelebration

👫🔴 Walking together for a good cause! Our colleagues from Fresenius Kabi in #Mirandola, Italy, joined the #RedWalk organized by the Association Donne in Centro together with their families and colleagues. They wore red to raise #awareness for the Elimination of Violence against Women.

#EliminationOfViolenceAgainstWomen #TeamFresenius

After years of navigating the challenges posed by the pandemic, it was an absolute joy to come together and spread some festive cheer at our Christmas Market in Bad Homburg this year! Over 4,000 employees and their wonderful families joined us for an unforgettable get-together.

🎄 The festivities included entertainment for both young and old alike. From Christmas Market Stalls offering traditional mulled wine to Advent Wreath Making Workshops, Face Painting for kids and Live Musicians: We fully embraced the Christmas spirit. 

As if that was not enough, we even invited Santa Claus himself for a special appearance among our little guests 😉🎅 

Thank you to everyone who joined us in making this Christmas Market a resounding success! Here's to a season filled with warmth, love, and the joy of coming together.

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 6, 2024 12:40 AM	7ef6f28b
translate crunchbase fundingrounds	general
peers	general	Feb 6, 2024 12:40 AM	9c7fe86e
news basic	general
events	markdown
bundesanzeiger	filings	Feb 12, 2024 3:21 PM	1cffa85c
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:FRESENIUS

Fresenius SE & Co. KGaA

Last Close

34.72

07/11 16:35

Market Cap

16.32B

Beta: -

Volume Today

1.69M

Avg: -